40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
63.91%
Revenue growth 1.25-1.5x VET's 46.20%. Bruce Berkowitz would examine if growth advantage is sustainable.
-7.63%
Cost reduction while VET shows 59.81% growth. Joel Greenblatt would examine competitive advantage.
467.26%
Gross profit growth exceeding 1.5x VET's 19.11%. David Dodd would verify competitive advantages.
324.06%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-16.70%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
12.50%
Other expenses growth less than half of VET's 14712.50%. David Dodd would verify if advantage is sustainable.
-15.95%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-11.40%
Total costs reduction while VET shows 25.17% growth. Joel Greenblatt would examine advantage.
12.79%
Interest expense growth while VET reduces costs. John Neff would investigate differences.
-17.65%
D&A reduction while VET shows 57.19% growth. Joel Greenblatt would examine efficiency.
70.04%
EBITDA growth 1.25-1.5x VET's 62.67%. Bruce Berkowitz would examine sustainability.
151.65%
Similar EBITDA margin growth to VET's 183.82%. Walter Schloss would investigate industry trends.
62.90%
Operating income growth exceeding 1.5x VET's 30.52%. David Dodd would verify competitive advantages.
77.36%
Operating margin growth 1.25-1.5x VET's 52.47%. Bruce Berkowitz would examine sustainability.
-80.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
61.85%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
76.72%
Pre-tax margin growth exceeding 1.5x VET's 19.58%. David Dodd would verify competitive advantages.
-113.27%
Both companies reducing tax expense. Martin Whitman would check patterns.
65.30%
Net income growth exceeding 1.5x VET's 1.91%. David Dodd would verify competitive advantages.
78.83%
Net margin growth exceeding 1.5x VET's 32.91%. David Dodd would verify competitive advantages.
65.32%
EPS growth exceeding 1.5x VET's 2.22%. David Dodd would verify competitive advantages.
65.32%
Diluted EPS growth exceeding 1.5x VET's 2.22%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
